Tapentadol is a centrally acting opioid analgesic that is primarily used to manage moderate to severe pain. It is available in both immediate-release and extended-release formulations and is marketed under the brand names Nucynta and Palexia. Tapentadol works by binding to the mu-opioid receptors in the brain and spinal cord, which leads to a decrease in pain perception. It also inhibits the reuptake of norepinephrine, which helps to enhance its analgesic effects.
Topics